Basic Information
LncRNA/CircRNA Name | MALAT1 |
Synonyms | MALAT1, HCN, LINC00047, NCRNA00047, NEAT2, PRO2853 |
Region | GRCh38_11:65497688-65506516 |
Ensemble | ENSG00000251562 |
Refseq | NR_002819 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | thyroid cancer |
ICD-0-3 | C73.9 |
Methods | qPCR, Western blot |
Sample | thyroid cancer tissues, cell lines (SW1736, KAT18, FTC133, HGC-27) |
Expression Pattern | up-regulated |
Function Description | The higher levels of MALAT-1 and FGF2 were observed in thyroid cancer tissues and in thyroid cancer cells compared to that in the control.in the presence of si-MALAT1, the levels of TNF-a and IL-12 were significantly up-regulated whereas IL-10 was down-regulated in the CM from TAMs. |
Pubmed ID | 28543663 |
Year | 2017 |
Title | LncRNA-MALAT1 Promotes Angiogenesis of Thyroid Cancer by Modulating Tumor-Associated Macrophage FGF2 Protein Secretion.down-regulation of MALAT1 in TAMs reduced proliferation, migration, and invasion of FTC133 cells and inhibited angiogenesis.overexpression of FGF2 blocked the effects of MALAT1 siRNAs on cell migration, invasion, and angiogenesis.MALAT1-mediated FGF2 protein secretion from TAMs inhibits inflammatory cytokines release, promotes proliferation,migration, and invasion of FTC133 cells and induces vasculature formation. |
External Links
Links for MALAT1 | GenBank HGNC NONCODE |
Links for thyroid cancer | OMIM COSMIC |